封面
市场调查报告书
商品编码
1609701

2025-2033 年日本止血剂市场报告(按产品、配方、应用和地区)

Japan Hemostats Market Report by Product, Formulation, Application, and Region 2025-2033

出版日期: | 出版商: IMARC | 英文 119 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024 年日本止血剂IMARC Group规模达 2.203 亿美元。心血管疾病、癌症和糖尿病等慢性疾病的盛行率不断上升,以及手术介入需求的不断增加,正在推动市场的发展。

止血钳是用于在医疗手术过程中控制出血的手术器械。它们由两个铰接的剪刀状手柄组成,工作端带有锯齿状钳口。这些钳口可以锁定到位以夹住血管或组织,有效地将它们夹紧以防止进一步出血。止血钳通常用于小型和大型手术以及急诊室和牙科诊所等各种医疗环境。止血钳的关键功能是提供精确和暂时的血管闭塞,使医疗保健专业人员能够安全有效地工作,而不会因过度失血而妨碍他们的手术。它们有各种尺寸和设计,具有直或弯曲的尖端,以满足不同的手术需求。止血钳也可用于在手术过程中抓住和操纵脆弱的组织。它们的多功能性使它们成为医疗领域的宝贵工具,有助于实现止血并确保成功的手术结果,同时最大限度地减少因失血过多而导致併发症的风险。

日本止血剂市场趋势:

有几个关键因素正在推动止血剂市场的成长。首先,日本外科手术数量的增加对止血剂产生了强烈的需求。随着手术变得更加先进和微创,在这些手术过程中对有效止血剂控制出血的需求激增。此外,人口老化对市场扩张做出了重大贡献。随着老年人口的不断增加,慢性病和外科手术(例如心血管和骨科手术)的发生率不断上升,进一步推动了对止血产品的需求。此外,止血技术的进步在市场扩张中发挥了关键作用。具有增强功效和安全性的创新产品受到医疗保健专业人士的青睐,推动了市场成长。此外,医疗保健提供者和患者对止血产品及其益处的认识不断提高,对市场动态产生了积极影响。此外,市场对研发活动的投资激增,促进了新型止血解决方案的推出。製药公司和研究机构之间的合作正在突破创新的界限,为止血剂市场创造新的机会。这些相互关联的驱动因素正在推动区域止血剂市场的持续成长,并预计在未来几年塑造其发展轨迹。

日本止血剂市场区隔:

产品见解:

  • 基于凝血酶
  • 基于组合
  • 氧化再生纤维素基
  • 明胶基
  • 基于胶原蛋白

配方见解:

  • 基质止血剂和凝胶止血剂
  • 止血片和止血垫
  • 海绵止血钳
  • 粉末止血剂

应用见解:

  • 骨科手术
  • 一般外科
  • 神经外科
  • 心血管外科
  • 重建手术
  • 妇科手术
  • 其他的

竞争格局:

市场研究报告也对市场竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外,也提供了所有主要公司的详细资料。

本报告回答的关键问题:

  • 到目前为止,日本止血剂市场表现如何,未来几年又会如何表现?
  • COVID-19 对日本止血剂市场有何影响?
  • 日本止血剂市场依产品划分是怎样的?
  • 日本止血剂市场依配方划分是怎样的?
  • 日本止血剂市场的应用如何?
  • 日本止血剂市场价值链的各个阶段是什么?
  • 日本止血剂的关键驱动因素和挑战是什么?
  • 日本止血剂市场的结构如何?
  • 日本止血剂市场的竞争程度如何?

本报告回答的关键问题:

  • 到目前为止,日本止血剂市场表现如何,未来几年又会如何表现?
  • COVID-19 对日本止血剂市场有何影响?
  • 日本止血剂市场依产品划分是怎样的?
  • 日本止血剂市场依配方划分是怎样的?
  • 日本止血剂市场的应用如何?
  • 日本止血剂市场价值链的各个阶段是什么?
  • 日本止血剂的关键驱动因素和挑战是什么?
  • 日本止血剂市场的结构如何?
  • 日本止血剂市场的竞争程度如何?

目录

第一章:前言

第 2 章:范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章:执行摘要

第 4 章:日本止血剂市场 - 简介

  • 概述
  • 市场动态
  • 产业动态
  • 竞争情报

第 5 章:日本止血剂市场格局

  • 历史与当前市场趋势(2019-2024)
  • 市场预测(2025-2033)

第 6 章:日本止血剂市场 - 细分:依产品分类

  • 基于凝血酶
    • 概述
    • 历史与当前市场趋势(2019-2024)
    • 市场预测(2025-2033)
  • 基于组合
    • 概述
    • 历史与当前市场趋势(2019-2024)
    • 市场预测(2025-2033)
  • 氧化再生纤维素基
    • 概述
    • 历史与当前市场趋势(2019-2024)
    • 市场预测(2025-2033)
  • 明胶基
    • 概述
    • 历史与当前市场趋势(2019-2024)
    • 市场预测(2025-2033)
  • 基于胶原蛋白
    • 概述
    • 历史与当前市场趋势(2019-2024)
    • 市场预测(2025-2033)

第 7 章:日本止血剂市场 - 细分:按配方

  • 基质止血剂和凝胶止血剂
    • 概述
    • 历史与当前市场趋势(2019-2024)
    • 市场预测(2025-2033)
  • 止血片和止血垫
    • 概述
    • 历史与当前市场趋势(2019-2024)
    • 市场预测(2025-2033)
  • 海绵止血器
    • 概述
    • 历史与当前市场趋势(2019-2024)
    • 市场预测(2025-2033)
  • 粉末止血剂
    • 概述
    • 历史与当前市场趋势(2019-2024)
    • 市场预测(2025-2033)

第 8 章:日本止血剂市场 - 细分:按应用分类

  • 骨科手术
    • 概述
    • 历史与当前市场趋势(2019-2024)
    • 市场预测(2025-2033)
  • 一般外科
    • 概述
    • 历史与当前市场趋势(2019-2024)
    • 市场预测(2025-2033)
  • 神经外科
    • 概述
    • 历史与当前市场趋势(2019-2024)
    • 市场预测(2025-2033)
  • 心血管外科
    • 概述
    • 历史与当前市场趋势(2019-2024)
    • 市场预测(2025-2033)
  • 重建手术
    • 概述
    • 历史与当前市场趋势(2019-2024)
    • 市场预测(2025-2033)
  • 妇科手术
    • 概述
    • 历史与当前市场趋势(2019-2024)
    • 市场预测(2025-2033)
  • 其他的
    • 历史与当前市场趋势(2019-2024)
    • 市场预测(2025-2033)

第 9 章:日本止血剂市场 - 竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳制胜策略
  • 竞争仪表板
  • 公司评估象限

第 10 章:关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 11 章:日本止血器市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 司机
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 12 章:附录

简介目录
Product Code: SR112024A19019

Japan hemostats market size reached USD 220.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 362.6 Million by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. The escalating prevalence of chronic diseases such as cardiovascular diseases, cancer, and diabetes, along with the rising need for surgical interventions, is driving the market.

Hemostats are surgical instruments used to control bleeding during medical procedures. They consist of two hinged, scissor-like handles with serrated jaws at the working end. These jaws can be locked in place to grip blood vessels or tissues, effectively clamping them shut to prevent further bleeding. Hemostats are commonly used in surgeries, both minor and major, as well as in various medical settings like emergency rooms and dental offices. The key function of hemostats is to provide precise and temporary occlusion of blood vessels, allowing healthcare professionals to work safely and effectively without excessive bleeding hindering their procedures. They come in various sizes and designs, with straight or curved tips, to accommodate different surgical needs. Hemostats can also be used to grasp and manipulate delicate tissues during surgery. Their versatility makes them invaluable tools in the medical field, aiding in achieving hemostasis and ensuring successful surgical outcomes while minimizing the risk of complications due to excessive bleeding.

Japan Hemostats Market Trends:

Several key factors are driving growth in the hemostats market. Firstly, the increasing number of surgical procedures in Japan has created a robust demand for hemostatic agents. As surgeries become more advanced and minimally invasive, the need for effective hemostats to control bleeding during these procedures has surged. Furthermore, the aging population is contributing significantly to market expansion. With a growing elderly demographic, the incidence of chronic diseases and surgeries, such as cardiovascular and orthopedic procedures, has risen, further propelling the demand for hemostatic products. Additionally, advancements in hemostatic technologies have played a pivotal role in market expansion. Innovative products with enhanced efficacy and safety profiles have gained traction among healthcare professionals, driving market growth. Furthermore, the increasing awareness of hemostatic products and their benefits among both healthcare providers and patients has positively influenced market dynamics. Moreover, the market is witnessing a surge in investment in R&D activities, fostering the introduction of novel hemostatic solutions. Collaborations between pharmaceutical companies and research institutions are pushing the boundaries of innovation, creating new opportunities in the hemostats market. These interconnected drivers are fueling the regional hemostats market's continued growth and are expected to shape its trajectory in the coming years.

Japan Hemostats Market Segmentation:

Product Insights:

  • Thrombin Based
  • Combination Based
  • Oxidized Regenerated Cellulose Based
  • Gelatin Based
  • Collagen Based

Formulation Insights:

  • Matrix and Gel Hemostats
  • Sheet and Pad Hemostats
  • Sponge Hemostats
  • Powder Hemostats

Application Insights:

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Reconstructive Surgery
  • Gynecological Surgery
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan hemostats market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan hemostats market?
  • What is the breakup of the Japan hemostats market on the basis of product?
  • What is the breakup of the Japan hemostats market on the basis of formulation?
  • What is the breakup of the Japan hemostats market on the basis of application?
  • What are the various stages in the value chain of the Japan hemostats market?
  • What are the key driving factors and challenges in the Japan hemostats?
  • What is the structure of the Japan hemostats market and who are the key players?
  • What is the degree of competition in the Japan hemostats market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Hemostats Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Hemostats Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Hemostats Market - Breakup by Product

  • 6.1 Thrombin Based
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Combination Based
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Oxidized Regenerated Cellulose Based
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Gelatin Based
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Collagen Based
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2019-2024)
    • 6.5.3 Market Forecast (2025-2033)

7 Japan Hemostats Market - Breakup by Formulation

  • 7.1 Matrix and Gel Hemostats
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Sheet and Pad Hemostats
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Sponge Hemostats
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Powder Hemostats
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)

8 Japan Hemostats Market - Breakup by Application

  • 8.1 Orthopedic Surgery
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 General Surgery
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Neurological Surgery
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)
  • 8.4 Cardiovascular Surgery
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2019-2024)
    • 8.4.3 Market Forecast (2025-2033)
  • 8.5 Reconstructive Surgery
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2019-2024)
    • 8.5.3 Market Forecast (2025-2033)
  • 8.6 Gynecological Surgery
    • 8.6.1 Overview
    • 8.6.2 Historical and Current Market Trends (2019-2024)
    • 8.6.3 Market Forecast (2025-2033)
  • 8.7 Others
    • 8.7.1 Historical and Current Market Trends (2019-2024)
    • 8.7.2 Market Forecast (2025-2033)

9 Japan Hemostats Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Hemostats Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix